Lisata Therapeutics, Inc.
Lisata Therapeutics, Inc. (LSTA) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · LSTA · as of Jun 9, 2026
Key Statistics
Explore Lisata Therapeutics, Inc. Data
lsta stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 2 · Buy rate: 0.0%
Competitors & Peers
lsta competitorsLSTA
CASI
CLGN
CLSD
ENLV
KLTOStock Performance
Full HistoryAbout Lisata Therapeutics, Inc.
Lisata Therapeutics, Inc. is a clinical-stage biopharmaceutical firm focused on pioneering and bringing to market cellular therapies. These treatments are designed to either reverse disease progressio…
what is lisata therapeutics, inc. · lsta stock overview · lisata therapeutics, inc. company profile · who is lisata therapeutics, inc. ceo · lsta NASDAQ · lisata therapeutics, inc. headquarters · lisata therapeutics, inc. business segments
About Stock Overview & Key Data
Lisata Therapeutics, Inc. (LSTA) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Mar 1, 1999. As of the latest trading session, LSTA stock price is $3.48, with a market capitalization of $31.7M. The stock has returned +32.32% over the past 12 months and +87.10% year-to-date.
According to 2 Wall Street analysts, the consensus rating for Lisata Therapeutics, Inc. stock is Hold, with an average 12-month price target of $—. In fiscal year 2025, Lisata Therapeutics, Inc. reported revenue of $170000.00 and net income of -$16.6M. For detailed data — including Lisata Therapeutics, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Lisata Therapeutics, Inc. (LSTA) stock price is $3.48. The stock is traded on NASDAQ under the ticker symbol LSTA. The 52-week range is $1.81 – $5.07.